Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Seminars in Oncology|September 26, 2003
New directions in the management of chemotherapy-induced neutropenia: Risk models, special populations, and quality of lifeHoward OzerOncology (Williston Park, N.Y.)|June 2, 2006
The timing of chemotherapy-induced neutropenia and its clinical and economic impactHoward OzerExpert Opinion on Investigational Drugs|September 29, 2009
Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancerPrithviraj Bose, Howard OzerOncology (Williston Park, N.Y.)|March 21, 2007
First-Cycle CSF use in breast cancer and NHL: guidelines and recommendationsAref Al-Kali, Howard OzerSeminars in Oncology|February 24, 2005
Perspectives in the treatment of colorectal cancerHoward Ozer, Robert B DiasioDigestive Diseases and Sciences|April 15, 2006
Successful treatment of Helicobacter pylori-negative gastric MALT lymphoma with rituximabNadeem Chaudhary, Howard Ozer, David Huard, et al.Open Journal of Clinical & Medical Case Reports|December 23, 2015
Symptomatic Massive Splenomegaly in Persistent Polyclonal B-cell Lymphocytosis Requiring SplenectomyShanel B Bhagwandin, Elliot S Weisenberg, Howard Ozer, et al.The Journal of the Oklahoma State Medical Association|May 18, 2006
Marginal zone B-cell lymphoma of the uterus: a case report and review of the literatureMehdi Hamadani, M Kharfan-Dabaja, Rammurti Kamble, et al.Critical Reviews in Oncology/Hematology|December 5, 2017
MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive reviewBhavesh K Ahir, Howard Ozer, Herbert H Engelhard, et al.Clinical Lymphoma & Myeloma|July 11, 2007
Low incidence of neutropenic events in patients with lymphoma receiving first-cycle pegfilgrastim with chemotherapy: results from a prospective community-based studyStephen J Noga, Janak K Choksi, Beiying Ding, et al.Pageof 4